CD59 and hyperinsulinemic hypoglycemia, familial, 4: Therefore, treatment with eculizumab proved also effective in congenital CD59 deficiency; with a marked clinical improvement of these children, a reduction of hospitalizations and a reduction of IVIg and steroid doses [18].